I Caroline Le Poole Selected Research

I Caroline Le Poole Research Topics

Disease

24	Neoplasms (Cancer) 11/2021 - 02/2002
20	Vitiligo 01/2021 - 01/2004
18	Melanoma (Melanoma, Malignant) 01/2021 - 02/2002
4	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2020 - 12/2009
3	Inflammation (Inflammations) 01/2021 - 01/2008
3	Wounds and Injuries (Trauma) 08/2008 - 01/2004
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2004 - 01/2003
2	Cysts 01/2020 - 01/2012
1	Tuberous Sclerosis (Bourneville's Disease) 11/2021
1	Dysbiosis 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Infections 09/2013
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2013
1	Dyspnea (Shortness of Breath) 01/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2011
1	Multiple Sclerosis 07/2011
1	Disease Progression 07/2011
1	Cutaneous Malignant Melanoma 04/2011
1	Skin Neoplasms (Skin Cancer) 09/2008
1	Autoimmune Diseases (Autoimmune Disease) 08/2008
1	Microphthalmos 10/2004
1	Venezuelan Equine Encephalomyelitis 01/2004
1	Retinoblastoma (Glioblastoma, Retinal) 01/2004
1	Papillomavirus Infections 01/2003
1	Neoplasm Metastasis (Metastasis) 02/2002

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 01/2020 - 02/2002
6	VaccinesIBA 01/2012 - 01/2003
5	CytokinesIBA 02/2021 - 01/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2003
5	Proteins (Proteins, Gene)FDA Link 09/2013 - 01/2004
4	GangliosidesIBA 11/2021 - 07/2013
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021 - 01/2004
4	Peptides (Polypeptides)IBA 05/2016 - 02/2002
3	lipoarabinomannan (LAM)IBA 01/2020 - 01/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 07/2011
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 02/2013
3	Monophenol Monooxygenase (Tyrosinase)IBA 02/2018 - 12/2009
3	PhenolsIBA 03/2014 - 08/2008
3	Differentiation AntigensIBA 07/2013 - 01/2004
2	Chemokine CCL22IBA 10/2017 - 04/2010
2	CCR4 ReceptorsIBA 10/2017 - 04/2010
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 08/2014 - 09/2013
2	EpitopesIBA 08/2012 - 01/2004
2	Bleaching AgentsIBA 06/2011 - 04/2011
2	Interferon-gamma (Interferon, gamma)IBA 12/2009 - 02/2002
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	TOR Serine-Threonine KinasesIBA 11/2021
1	trans-sodium crocetinate (crocetin)IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 02/2018
1	Interleukin-2 (IL2)IBA 02/2018
1	alpha-N-acetylneuraminate alpha-2,8-sialyltransferaseIBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Chemotactic FactorsIBA 11/2016
1	ChemokinesIBA 11/2016
1	Toll-Like Receptor AgonistsIBA 08/2014
1	Imiquimod (Aldara)FDA LinkGeneric 08/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2014
1	Estrogen ReceptorsIBA 07/2013
1	OxygenasesIBA 06/2011
1	Heme (Haem)IBA 06/2011
1	Protein Isoforms (Isoforms)IBA 06/2011
1	Heme Oxygenase-1IBA 06/2011
1	LigandsIBA 04/2010
1	Phenol (Carbolic Acid)FDA Link 01/2010
1	Pharmaceutical PreparationsIBA 01/2010
1	Ether (Diethyl Ether)IBA 01/2010
1	hydroquinone (Esoterica)FDA Link 01/2010
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2009
1	G(M3) GangliosideIBA 11/2009
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2008
1	Basic Helix-Loop-Helix Transcription FactorsIBA 10/2004
1	Microphthalmia-Associated Transcription FactorIBA 10/2004
1	HLA-A*02:01 antigenIBA 01/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2004
1	Cancer VaccinesIBA 11/2002
1	interferon tauIBA 02/2002
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2002

Therapy/Procedure

10	Therapeutics 02/2021 - 02/2002
7	Immunotherapy 11/2021 - 01/2003
1	Lasers (Laser) 02/2002